6Chapoval AI, Tamada K , Chen L. In vitro growth inhibition of a brad spectrum of tumor cell lines by activated human dendritic cells. Blood,2000,95:2346-2351.
7Morisaki T, Katano M, Ikubo A, et al. Immunosuppressive cytokines(IL-10, TGF-beta) genes expression in human gastric carcinoma tissues. J Surg Oncol, 1996,63:234-239.
8Ishigami S, Natsugoe S, Tokuda K, el al. Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett,2000,159:103-108.
9Banchereau J, Steinman RM. Dendritic cells and the control of immunity . Nature, 1998,392:245-252.
10Gunzer M, Janich S, Varga G. Dendritic cells and tumor immunity.Semin Immunol,2001,13:291-302.
2Kanzaki N,Terashima M,Kashimura S,et al.Understanding the response of dendritic cells to activation by streptococcal preparation OK-432[J].Anticancer Res,2005,25(6B):4231-4238.
3Okamoto M,Furuichi S,Nishioka Y,et al.Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432,a streptococcal preparation[J].Cancer Res,2004,64(15):5461-5470.
4Wigginton J M,Gruys E,Geiselhart L,el al.TFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy[J].J Clin Invest,2001,108(1):51-62.
